06579851 is referenced by 43 patents and cites 2 patents.

The present invention provides an effective method for inhibiting antro-duodenal motility in healthy subjects and patients suffering from various disorders, without the side effects associated with other pharmaceutical compositions. GLP1(7-36)amide slows antro-duodenal motility and may be used for the treatment or prevention of gastrointestinal disorders such as diarrhea, postoperative dumping syndrome and irritable bowel syndrome, and also premedication in endoscopic procedures.

Title
Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
Application Number
9/805507
Publication Number
6579851 (B2)
Application Date
March 14, 2001
Publication Date
June 17, 2003
Inventor
Joerg Schirra
Kirchhain
US
Burkhard Goeke
Gauting
US
Agent
McKee Voorhees & Sease
US
Assignee
Amylin Pharmaceuticals
CA, US
IPC
A61K 38/26
View Original Source